AIM:PYC · Health Care · AIM-listed outsourced quantitative pharmacology (modelling & simulation) and biometrics consulting/contract research services to biopharmaceutical companies

Physiomics plc

Physiomics Plc is an AIM-listed Oxfordshire-based company providing outsourced consulting and contract research services to biopharmaceutical companies and research institutes, principally in Modelling & Simulation (quantitative pharmacology) and, from FY26, Biometrics (biostatistics, statistical programming and data management), supported by its proprietary Virtual Tumour software platform. It also develops a personalised-medicine dosing technology (funded largely by Innovate UK/NIHR grants) aimed at predicting optimal cancer drug dosing. The company operates a fee-for-service consulting business model and is loss-making but cash generative enough to fund operations alongside periodic equity fundraises.

Export the Physiomics plc factsheetfree account Open the FY2026 report

Share price and financials

No price history · 12 reported years, FY2015–FY2026

No daily prices have been collected for this company.

Line	FY2015locked	FY2016locked	FY2017locked	FY2018locked	FY2019locked	FY2020locked	FY2021locked	FY2022locked	FY2023locked
Revenue	0.44	0.65	0.97	0.88	1.1	1.0	0.83	0.61	1.0
Operating profit	(0.46)	(0.82)	(0.84)	(0.39)	(0.59)	(0.80)	(0.60)	(0.47)	(0.61)
Net finance cost	(0.00)	(0.00)	(0.00)	(0.00)	(0.00)	(0.00)	(0.00)	(0.00)	(0.00)
Profit before tax	(0.57)	(0.53)	(0.41)	(0.52)	(0.75)	(0.69)	(0.58)	(0.41)	(0.77)
Tax charge	(0.03)	(0.02)	(0.03)	(0.03)	(0.03)	(0.03)	(0.04)	(0.04)	(0.05)
Profit for the year	(0.46)	(0.42)	(0.33)	(0.67)	(0.61)	(0.52)	(0.42)	(0.36)	(0.47)
EBITDA	(0.76)	(0.33)	(0.81)	(0.61)	(0.52)	(0.52)	(0.61)	(0.51)	(0.80)
Basic EPS	(0.36p)	(0.24p)	(0.35p)	(0.22p)	(0.16p)	(0.32p)	(0.20p)	(0.17p)	(0.25p)
Diluted EPS	(0.32p)	(0.26p)	(0.27p)	(0.29p)	(0.35p)	(0.31p)	(0.31p)	(0.24p)	(0.23p)

GBP millions, negatives in brackets. Per-share lines in pence. later is what a following report restated the figure to; vs is a second reading that disagrees. The figure shown is the one the original filing printed, and both readings are kept. Click any figure: opens the report page it was read from, highlighted; shows how it was calculated.

2 figures

3 years, at a glance

GBP · %

Dashed: Operating margin, in % on its own scale — read its shape, not its height against the bars.

FY2026Revenue£941kOperating margin−73.0%